Checkpoint Inhibitor
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC (NCT04507906) | Shanghai Chest Hospital | 2020-11-02 |
| Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease (NCT04805099) | Hellenic Cooperative Oncology Group | 2020-11-01 |
| Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling (NCT06298123) | Chen Xiaoping | 2019-02-01 |
Track Checkpoint Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.